The DOI matches its Crossref record.
Treatment of Essential Hypertension with a New Vasodilator in Combination with Beta-Adrenergic Blockade
Abstract
A new piperidino-pyrimidine vasodilator (PDP) when used in the treatment of 11 hypertensive patients, lowered blood pressure from 188/124 to 159/100 over six to seven days. blood-pressure responses to standing, cold-pressor test and Valsalva maneuver persisted, and postural symptoms did not occur despite marked reduction of blood pressure. However, the antihypertensive action was associated with reflexly induced increases in heart rate, cardiac index and norepinephrine excretion and evidence of myocardial ischemia in some patients. Selective beta-adrenergic blockade with propranolol prevented this augmentation of cardiac activity and further decreased blood pressure. Although glomerular filtration rate and renal plasma flow were unchanged, sodium retention occurred in all patients. Such retention appeared to be readily controllable with oral diuretics in the one patient to whom it was given. Thus, PDP combined with propranolol results in highly effective lowering of blood pressure in hypertensive patients without attendant postural symptoms, and may provide an important new approach to antihypertensive therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The role of vasodilator therapy in heart failure
Chatterjee, K., & Parmley, W. W. (1977) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(77)90006-8 · Cited by 315
Oparil, S., & Haber, E. (1974) · New England Journal of Medicine · doi:10.1056/nejm197408222910805 · Cited by 308
Laurent, S. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.07.026 · Cited by 301
Minoxidil: An Underused Vasodilator for Resistant or Severe Hypertension
Sica, D. A. (2004) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2004.03585.x · Cited by 128
Metadata
- Authors
- Gilmore, E., Weil, J., & Chidsey, C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1970-03-05
- Volume
- 282
- Issue
- 10
- Pages
- 521-527
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2339719629
- Cited by
- 224
- References
- 0
- FWCI
- 13.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Essential Hypertension with a New Vasodilator in Combination with Beta-Adrenergic Blockade. https://app.cochat.ai/papers/10.1056/nejm197003052821001
- The paper
- Gilmore, E., Weil, J., & Chidsey, C. (1970). Treatment of Essential Hypertension with a New Vasodilator in Combination with Beta-Adrenergic Blockade. New England Journal of Medicine. https://doi.org/10.1056/nejm197003052821001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.